Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,738,545
-$668,995 QoQ
Shares Held
1,918,063
+6.8% QoQ
Ownership
3.17%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. VNDA ranks #16 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in VNDA
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,738,545 | 1,918,063 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $12,407,540 | 1,795,592 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $21,259,851 | 2,410,414 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $11,121,432 | 2,228,744 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,174,520 | 1,731,890 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $8,661,554 | 1,887,049 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $9,101,009 | 1,900,002 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $8,911,009 | 1,900,002 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,198,452 | 1,982,027 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $9,742,076 | 2,370,335 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $9,550,417 | 2,263,132 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,562,829 | 1,750,655 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,506,609 | 1,139,091 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $7,053,737 | 1,038,842 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,308,680 | 718,360 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,282,859 | 635,917 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $302,703 | 27,771 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $4,253,317 | 376,067 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $6,743,248 | 429,780 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $8,871,646 | 517,599 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 ALXN | — | 23,658 | Shares | Defined | 2021-08-11 | |
| 2021-06-30 | $13,010,065 | 604,838 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 ALXN | — | 23,471 | Shares | Defined | 2021-05-11 | |
| 2021-03-31 | $14,306,204 | 952,477 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 ALXN | — | 40,582 | Shares | Defined | 2021-02-11 | |
| 2020-12-31 | $13,030,662 | 991,679 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 ALXN | — | 53,404 | Shares | Defined | 2020-11-09 | |
| 2020-09-30 | $10,509,046 | 1,087,893 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 ALXN | — | 58,963 | Shares | Defined | 2020-08-12 | |
| 2020-06-30 | $12,243,843 | 1,070,266 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $12,087,716 | 1,166,768 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||